ENDRA LIFE SCIENCES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
ENDRA LIFE SCIENCES INC. (NDRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 53 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 1.00 shares, a 88.89% decline year-over-year.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 52.00 shares, a 1633.33% increase year-over-year.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 30.00 shares, a 2900.00% increase year-over-year.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 0.00 shares.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 42.00 shares, a 7.69% increase from fiscal 2024.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 39.00 shares, a 99.91% decline from fiscal 2023.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 41.79K shares, a 232.88% increase from fiscal 2022.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 12.55K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 53.00 shares 10-Q · filed 2026-08-14 | 83.00 shares derived: sum of 3 quarters · filed 2026-08-14 | 83.00 shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 52.00 shares 10-Q · filed 2026-05-15 | 82.00 shares derived: sum of 2 quarters · filed 2026-05-15 | 82.00 shares derived: sum of 3 quarters · filed 2026-05-15 | 91.00 shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | 30.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 30.00 shares derived: sum of 2 quarters · filed 2026-03-31 | 39.00 shares derived: sum of 3 quarters · filed 2026-03-31 | 42.00 shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 9.00 shares derived: sum of 2 quarters · filed 2025-11-14 | 12.00 shares 10-Q · filed 2025-11-14 | 13.00 shares derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | 9.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 12.00 shares 10-Q · filed 2025-08-14 | 13.00 shares derived: sum of 3 quarters · filed 2025-08-14 | -348.00 shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 3.00 shares 10-Q · filed 2025-05-15 | 4.00 shares derived: sum of 2 quarters · filed 2025-05-15 | -357.00 shares derived: sum of 3 quarters · filed 2025-05-15 | -257.00 shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | 1.00 shares derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07 | -360.00 shares derived: sum of 2 quarters · filed 2025-04-07 | -260.00 shares derived: sum of 3 quarters · filed 2025-04-07 | 39.00 shares 10-K/A · filed 2025-04-07 |
| 2024-09-30 | -361.00 shares derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-11-21 | -261.00 shares derived: sum of 2 quarters · filed 2024-11-21 | 38.00 shares 10-Q/A · filed 2024-11-21 | 38.00 shares derived: sum of 4 quarters · filed 2024-11-21 |
| 2024-06-30 | 100.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 399.00 shares 10-Q · filed 2024-08-14 | 399.00 shares derived: sum of 3 quarters · filed 2024-08-14 | 22.86K shares derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | 299.00 shares 10-Q · filed 2024-05-14 | 299.00 shares derived: sum of 2 quarters · filed 2024-05-14 | 22.76K shares derived: sum of 3 quarters · filed 2024-05-14 | 22.96K shares derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 22.46K shares derived: sum of 2 quarters · filed 2024-03-28 | 22.66K shares derived: sum of 3 quarters · filed 2024-03-28 | 41.79K shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 22.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 22.66K shares derived: sum of 2 quarters · filed 2023-11-14 | 41.79K shares 10-Q · filed 2023-11-14 | 6.58K shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 200.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 19.33K shares 10-Q · filed 2023-08-14 | -15.88K shares derived: sum of 3 quarters · filed 2023-08-14 | -15.88K shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 19.13K shares 10-Q · filed 2023-05-15 | -16.08K shares derived: sum of 2 quarters · filed 2023-05-15 | -16.08K shares derived: sum of 3 quarters · filed 2023-05-15 | |
| 2022-12-31 | -35.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -35.22K shares derived: sum of 2 quarters · filed 2023-03-16 | 12.55K shares 10-K · filed 2023-03-16 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 47.77K shares 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | 47.77K shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |